Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Indivior ( (GB:INDV) ) is now available.
Indivior PLC announced changes to the share interests of its CEO, Mark Crossley, following the release of awards under the Long-Term Incentive Plan. The awards, granted in 2020 and vested in 2023, were released in March 2025, resulting in Crossley holding 340,953 shares in the company. This transaction aligns with the UK Market Abuse Regulation, reflecting Indivior’s commitment to transparency and regulatory compliance.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and distribution of medications primarily for the treatment of addiction and related mental health disorders.
YTD Price Performance: -30.32%
Average Trading Volume: 334,440
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £889.4M
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue